SlideShare a Scribd company logo
European Regulatory
Framework for chemicals –
protecting citizens and the
environment
Jukka Malm
Deputy Executive Director
European Chemicals Agency
3 December 2019
2
Aims of the framework
• Protection of human health and the
environment from the harmful effects of
chemicals
• Support to the efficient functioning of the
single market of chemicals
• Support the global competitiveness of the
European chemicals industry
The European Chemicals Agency
• EU Agency operating in Helsinki since
2007
• Implementing several European
legislations related to chemicals
• 600 staff from 28 countries
• Funding partly from fees, partly from EU
subsidy
Our competences:
3
Working for the safe use of chemicals
Classification, labelling, packaging
substances and mixtures
Biocides
active substances in biocidal products
REACH
substances as such, in mixtures and articles
Waste
database of products
with substances of
concern
PIC
import and export
of hazardous
substances
POPs
persistent organic
pollutants
Workers
occupational
exposure limits
4
5
Main actors – REACH and CLP Regulations
Providing data Industry gathers information
and makes sure risks are
managed
Risk management European Commission, with
support of ECHA and Member
States, applies EU-wide risk
management measures
ECHA and Member States
screen and check the data
and request more if needed
Evaluation
More data on chemicals than ever before
201
substances of very high concern
600
risk management proposals
2200
substances checked for compliance
23 000
substances registered under REACH
145 000
substances classified under CLP
>2 million
study summaries on chemical properties and effects
6
• Information on hazards
and safe use of 140 000
chemicals
• 24 000 daily users
echa.europa.eu
Visit our regulatory chemicals
database – largest in the
world
8
Proposed restriction on microplastics
Prohibition on ‘placing on the market’
Uses where microplastic releases to the
environment are inevitable
Derogated uses
Natural/biodegradable polymers; uses with no
microplastic release; already regulated
Mandatory ‘safe use information’
Uses where microplastic release can be
minimised with instructions for use
Mandatory ‘reporting’
Identity, description of use (function), tonnage,
releases
Microplasticdefinition
System is working but
improvements are necessary
Reinforce the foundation
• Our goal: Robust data is available on all
chemicals in Europe
• We keep on working on compliance of industry dossiers
 Compliant data allows the substances to be adequately
classified, labelled and used safely
 We can conclude which substances
• are of concern;
• are currently not of concern; or
• need more data for a judgement to be made.
 Substances of concern are addressed via regulatory
risk management
10
REACH Evaluation Action Plan
• Ambition: ECHA to check 20% of
REACH registrations by 2027 for
compliance (current target 5%)
• 20% of registrations = around 30%
of chemical substances on EU market
• Two milestones:
• End 2023 for substances in
tonnage bands over 100
tonnes/year
• End 2027 for substances in the
1-100 tonnage bands/year
11
Building on the right foundation
• Safe and sustainable use of chemicals by
industry
• Ensure better compliance of supply chain
communication, but also go beyond
• Companies should move from reactive to proactive
• Encourage companies to integrate chemicals
management within corporate sustainability strategies
• Promote substitution – data, tools, best practice,
capacity building – avoid regrettable substitution
• Increasing demands from consumers, retailers &
investors
12
How investing in chemicals legislation
can benefit other legislation areas
REACH
CLP
Biocides
Occupational
health and
safety
Waste
framework
directive
Restriction of
Hazardous
Substances
directive
(RoHS)
End of life
vehicles
directive
Water
framework
directive
Drinking
water
directive
Improved consistency of
legislative framework
Stronger protection of
environment and human health
Boosting innovation and promoting
safe substitution
Knowledge and science for non-
toxic material cycles
Global standards
13
EU priorities
15
The zero pollution ambition is
dependent on the sustainable
production and use of chemicals
“For the health of our citizens, our
children and grandchildren, Europe
needs to move towards a zero-
pollution ambition. I will put forward
a cross-cutting strategy to protect
citizens’ health from environmental
degradation and pollution, addressing
air and water quality, hazardous
chemicals, industrial emissions,
pesticides and endocrine disrupters.”
Ursula von der Leyen
Chemicals in circular economy
• Material =
mixture of
chemicals
• Chemicals, waste, products interface
• Continue
generating hazard
data for substances
• Develop tracking and
tracing of substances in
material cycles
• Non-toxic material cycles
17
Thank you!
jukka.malm@echa.europa.eu
Subscribe to our news at
echa.europa.eu/subscribe
Follow us on Twitter
@EU_ECHA
Follow us on Facebook
Facebook.com/EUECHA

More Related Content

What's hot

June 9 2017 Panel 5 Ravi Agarwal
June 9 2017 Panel 5 Ravi AgarwalJune 9 2017 Panel 5 Ravi Agarwal
June 9 2017 Panel 5 Ravi Agarwal
Chemicals Forum Association
 
June 8 2017 Panel 1 Andrea Paetz
June 8 2017 Panel 1 Andrea PaetzJune 8 2017 Panel 1 Andrea Paetz
June 8 2017 Panel 1 Andrea Paetz
Chemicals Forum Association
 
June 9 2017 Panel 5 Karin Kilian
June 9 2017 Panel 5 Karin KilianJune 9 2017 Panel 5 Karin Kilian
June 9 2017 Panel 5 Karin Kilian
Chemicals Forum Association
 
Jim Jones: Keynote Presentation, CEC Chemicals Management Forum
Jim Jones: Keynote Presentation, CEC Chemicals Management ForumJim Jones: Keynote Presentation, CEC Chemicals Management Forum
Jim Jones: Keynote Presentation, CEC Chemicals Management Forum
North American Commission for Environmental Cooperation
 
June 8 2017 Panel 1 Jake Sanderson
June 8 2017 Panel 1 Jake SandersonJune 8 2017 Panel 1 Jake Sanderson
June 8 2017 Panel 1 Jake Sanderson
Chemicals Forum Association
 
Global Forum on Environment dedicated to chemicals management: Satoru Morishi...
Global Forum on Environment dedicated to chemicals management: Satoru Morishi...Global Forum on Environment dedicated to chemicals management: Satoru Morishi...
Global Forum on Environment dedicated to chemicals management: Satoru Morishi...
OECD Environment
 
Safer chemicals within REACH
Safer chemicals within REACHSafer chemicals within REACH
Safer chemicals within REACH
Greenpeace Argentina
 
HCF 2016: Peter Kearns
HCF 2016: Peter KearnsHCF 2016: Peter Kearns
HCF 2016: Peter Kearns
Chemicals Forum Association
 
GOTS & REACH for Textile Industry
GOTS & REACH for Textile IndustryGOTS & REACH for Textile Industry
GOTS & REACH for Textile Industry
kanhaiya kumawat
 
Global Forum on Environment dedicated to chemicals management: Sebahattin Dö...
Global Forum on Environment dedicated to chemicals management:  Sebahattin Dö...Global Forum on Environment dedicated to chemicals management:  Sebahattin Dö...
Global Forum on Environment dedicated to chemicals management: Sebahattin Dö...
OECD Environment
 
June 8 2017 Keynote Jim Jones
June 8 2017 Keynote Jim JonesJune 8 2017 Keynote Jim Jones
June 8 2017 Keynote Jim Jones
Chemicals Forum Association
 
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
Association of the British Pharmaceutical Industry (ABPI)
 
Global Forum on Environment dedicated to chemicals management: Monika Gail M...
Global Forum on Environment dedicated to chemicals management:  Monika Gail M...Global Forum on Environment dedicated to chemicals management:  Monika Gail M...
Global Forum on Environment dedicated to chemicals management: Monika Gail M...
OECD Environment
 
HCF 2018 Keynote: And Prosper, Marco Mensink, CEFIC
HCF 2018 Keynote: And Prosper, Marco Mensink, CEFICHCF 2018 Keynote: And Prosper, Marco Mensink, CEFIC
HCF 2018 Keynote: And Prosper, Marco Mensink, CEFIC
Chemicals Forum Association
 
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
Association of the British Pharmaceutical Industry (ABPI)
 
Global Implications of REACH and TSCA IUR
Global Implications of REACH and TSCA IURGlobal Implications of REACH and TSCA IUR
Global Implications of REACH and TSCA IUR
JSibblies
 
Key messages for policy makers
Key messages for policy makersKey messages for policy makers
Key messages for policy makers
EMPHASIS PROJECT
 
SCIP Database FAQ
SCIP Database FAQSCIP Database FAQ
SCIP Database FAQ
Kelly Haugen
 
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
Merck Life Sciences
 
Promoting Responsible Agricultural Supply Chains – Coralie David, OECD & FAO
Promoting Responsible Agricultural Supply Chains – Coralie David, OECD & FAOPromoting Responsible Agricultural Supply Chains – Coralie David, OECD & FAO
Promoting Responsible Agricultural Supply Chains – Coralie David, OECD & FAO
CIFOR-ICRAF
 

What's hot (20)

June 9 2017 Panel 5 Ravi Agarwal
June 9 2017 Panel 5 Ravi AgarwalJune 9 2017 Panel 5 Ravi Agarwal
June 9 2017 Panel 5 Ravi Agarwal
 
June 8 2017 Panel 1 Andrea Paetz
June 8 2017 Panel 1 Andrea PaetzJune 8 2017 Panel 1 Andrea Paetz
June 8 2017 Panel 1 Andrea Paetz
 
June 9 2017 Panel 5 Karin Kilian
June 9 2017 Panel 5 Karin KilianJune 9 2017 Panel 5 Karin Kilian
June 9 2017 Panel 5 Karin Kilian
 
Jim Jones: Keynote Presentation, CEC Chemicals Management Forum
Jim Jones: Keynote Presentation, CEC Chemicals Management ForumJim Jones: Keynote Presentation, CEC Chemicals Management Forum
Jim Jones: Keynote Presentation, CEC Chemicals Management Forum
 
June 8 2017 Panel 1 Jake Sanderson
June 8 2017 Panel 1 Jake SandersonJune 8 2017 Panel 1 Jake Sanderson
June 8 2017 Panel 1 Jake Sanderson
 
Global Forum on Environment dedicated to chemicals management: Satoru Morishi...
Global Forum on Environment dedicated to chemicals management: Satoru Morishi...Global Forum on Environment dedicated to chemicals management: Satoru Morishi...
Global Forum on Environment dedicated to chemicals management: Satoru Morishi...
 
Safer chemicals within REACH
Safer chemicals within REACHSafer chemicals within REACH
Safer chemicals within REACH
 
HCF 2016: Peter Kearns
HCF 2016: Peter KearnsHCF 2016: Peter Kearns
HCF 2016: Peter Kearns
 
GOTS & REACH for Textile Industry
GOTS & REACH for Textile IndustryGOTS & REACH for Textile Industry
GOTS & REACH for Textile Industry
 
Global Forum on Environment dedicated to chemicals management: Sebahattin Dö...
Global Forum on Environment dedicated to chemicals management:  Sebahattin Dö...Global Forum on Environment dedicated to chemicals management:  Sebahattin Dö...
Global Forum on Environment dedicated to chemicals management: Sebahattin Dö...
 
June 8 2017 Keynote Jim Jones
June 8 2017 Keynote Jim JonesJune 8 2017 Keynote Jim Jones
June 8 2017 Keynote Jim Jones
 
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
 
Global Forum on Environment dedicated to chemicals management: Monika Gail M...
Global Forum on Environment dedicated to chemicals management:  Monika Gail M...Global Forum on Environment dedicated to chemicals management:  Monika Gail M...
Global Forum on Environment dedicated to chemicals management: Monika Gail M...
 
HCF 2018 Keynote: And Prosper, Marco Mensink, CEFIC
HCF 2018 Keynote: And Prosper, Marco Mensink, CEFICHCF 2018 Keynote: And Prosper, Marco Mensink, CEFIC
HCF 2018 Keynote: And Prosper, Marco Mensink, CEFIC
 
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
 
Global Implications of REACH and TSCA IUR
Global Implications of REACH and TSCA IURGlobal Implications of REACH and TSCA IUR
Global Implications of REACH and TSCA IUR
 
Key messages for policy makers
Key messages for policy makersKey messages for policy makers
Key messages for policy makers
 
SCIP Database FAQ
SCIP Database FAQSCIP Database FAQ
SCIP Database FAQ
 
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
 
Promoting Responsible Agricultural Supply Chains – Coralie David, OECD & FAO
Promoting Responsible Agricultural Supply Chains – Coralie David, OECD & FAOPromoting Responsible Agricultural Supply Chains – Coralie David, OECD & FAO
Promoting Responsible Agricultural Supply Chains – Coralie David, OECD & FAO
 

Similar to Jukka Malm: European Regulatory Framework for Chemicals - Protecting Citizens and the Environment

HCF 2019 Keynote: The role of chemicals in the circulary economy
HCF 2019 Keynote: The role of chemicals in the circulary economyHCF 2019 Keynote: The role of chemicals in the circulary economy
HCF 2019 Keynote: The role of chemicals in the circulary economy
Chemicals Forum Association
 
Safety issues in chemical engineering
Safety issues in chemical engineering Safety issues in chemical engineering
Safety issues in chemical engineering
South-Eastern Finland University of Applied Sciences
 
New Product Registration - Key Considerations when Registering New Products
New Product Registration - Key Considerations when Registering New ProductsNew Product Registration - Key Considerations when Registering New Products
New Product Registration - Key Considerations when Registering New Products
Covance
 
OECD Green Talks LIVE: Global eChemPortal to information on chemical substances
OECD Green Talks LIVE: Global eChemPortal to information on chemical substancesOECD Green Talks LIVE: Global eChemPortal to information on chemical substances
OECD Green Talks LIVE: Global eChemPortal to information on chemical substances
OECD Environment
 
HCF 2016: Erika Kunz
HCF 2016: Erika KunzHCF 2016: Erika Kunz
HCF 2016: Erika Kunz
Chemicals Forum Association
 
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
MilliporeSigma
 
HCF 2016: Christel Musset
HCF 2016: Christel MussetHCF 2016: Christel Musset
HCF 2016: Christel Musset
Chemicals Forum Association
 
Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...
Irish Pharmaceutical Healthcare Association (IPHA)
 
SPHS Presentation at #COP21
SPHS Presentation at #COP21SPHS Presentation at #COP21
SPHS Presentation at #COP21
UN SPHS
 
The international movement to Clean Production
The international movement to Clean ProductionThe international movement to Clean Production
The international movement to Clean Production
Greenpeace Argentina
 
Bluesign Innovation For Extremes 06.05.2009
Bluesign Innovation For Extremes 06.05.2009Bluesign Innovation For Extremes 06.05.2009
Bluesign Innovation For Extremes 06.05.2009
Mary Rose
 
REACh Primer
REACh PrimerREACh Primer
REACh Primer
verdantlaw
 
CleanMed 2017
CleanMed 2017CleanMed 2017
CleanMed 2017
UN SPHS
 
Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
 Presentation: Developing Science-Informed Policy Responses to Curb Endocrine... Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
OECD Environment
 
Animal testing safety endpoints in chemical industry
Animal testing safety endpoints in chemical industryAnimal testing safety endpoints in chemical industry
Animal testing safety endpoints in chemical industry
MIHIR PUJARA
 
Biocides - obligations and novelties
Biocides - obligations and noveltiesBiocides - obligations and novelties
Biocides - obligations and novelties
UrskaPoje
 
Green Talks LIVE webinar: Pharmaceutical Residues in Freshwater
Green Talks LIVE webinar: Pharmaceutical Residues in FreshwaterGreen Talks LIVE webinar: Pharmaceutical Residues in Freshwater
Green Talks LIVE webinar: Pharmaceutical Residues in Freshwater
OECD Environment
 
HCF Final Report 2019
HCF Final Report 2019HCF Final Report 2019
HCF Final Report 2019
Chemicals Forum Association
 
SMi Group's Pharmaceutical Microbiology UK 2020
SMi Group's Pharmaceutical Microbiology UK 2020SMi Group's Pharmaceutical Microbiology UK 2020
SMi Group's Pharmaceutical Microbiology UK 2020
Dale Butler
 

Similar to Jukka Malm: European Regulatory Framework for Chemicals - Protecting Citizens and the Environment (20)

HCF 2019 Keynote: The role of chemicals in the circulary economy
HCF 2019 Keynote: The role of chemicals in the circulary economyHCF 2019 Keynote: The role of chemicals in the circulary economy
HCF 2019 Keynote: The role of chemicals in the circulary economy
 
Safety issues in chemical engineering
Safety issues in chemical engineering Safety issues in chemical engineering
Safety issues in chemical engineering
 
New Product Registration - Key Considerations when Registering New Products
New Product Registration - Key Considerations when Registering New ProductsNew Product Registration - Key Considerations when Registering New Products
New Product Registration - Key Considerations when Registering New Products
 
OECD Green Talks LIVE: Global eChemPortal to information on chemical substances
OECD Green Talks LIVE: Global eChemPortal to information on chemical substancesOECD Green Talks LIVE: Global eChemPortal to information on chemical substances
OECD Green Talks LIVE: Global eChemPortal to information on chemical substances
 
HCF 2016: Erika Kunz
HCF 2016: Erika KunzHCF 2016: Erika Kunz
HCF 2016: Erika Kunz
 
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
 
HCF 2016: Christel Musset
HCF 2016: Christel MussetHCF 2016: Christel Musset
HCF 2016: Christel Musset
 
Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...
 
SPHS Presentation at #COP21
SPHS Presentation at #COP21SPHS Presentation at #COP21
SPHS Presentation at #COP21
 
NatureNanotechnology2011
NatureNanotechnology2011NatureNanotechnology2011
NatureNanotechnology2011
 
The international movement to Clean Production
The international movement to Clean ProductionThe international movement to Clean Production
The international movement to Clean Production
 
Bluesign Innovation For Extremes 06.05.2009
Bluesign Innovation For Extremes 06.05.2009Bluesign Innovation For Extremes 06.05.2009
Bluesign Innovation For Extremes 06.05.2009
 
REACh Primer
REACh PrimerREACh Primer
REACh Primer
 
CleanMed 2017
CleanMed 2017CleanMed 2017
CleanMed 2017
 
Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
 Presentation: Developing Science-Informed Policy Responses to Curb Endocrine... Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
 
Animal testing safety endpoints in chemical industry
Animal testing safety endpoints in chemical industryAnimal testing safety endpoints in chemical industry
Animal testing safety endpoints in chemical industry
 
Biocides - obligations and novelties
Biocides - obligations and noveltiesBiocides - obligations and novelties
Biocides - obligations and novelties
 
Green Talks LIVE webinar: Pharmaceutical Residues in Freshwater
Green Talks LIVE webinar: Pharmaceutical Residues in FreshwaterGreen Talks LIVE webinar: Pharmaceutical Residues in Freshwater
Green Talks LIVE webinar: Pharmaceutical Residues in Freshwater
 
HCF Final Report 2019
HCF Final Report 2019HCF Final Report 2019
HCF Final Report 2019
 
SMi Group's Pharmaceutical Microbiology UK 2020
SMi Group's Pharmaceutical Microbiology UK 2020SMi Group's Pharmaceutical Microbiology UK 2020
SMi Group's Pharmaceutical Microbiology UK 2020
 

More from THL

Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021
THL
 
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdfNiiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
THL
 
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdfYlitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
THL
 
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdfNieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
THL
 
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdfRaitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
THL
 
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
THL
 
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdfLansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
THL
 
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdfMarkkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
THL
 
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
THL
 
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilastoRikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
THL
 
Synthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in EuropeSynthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in Europe
THL
 
Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021
THL
 
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
THL
 
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdfAktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
THL
 
Kort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationerKort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationer
THL
 
Förvaring av vacciner
Förvaring av vaccinerFörvaring av vacciner
Förvaring av vacciner
THL
 
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
THL
 
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikatauluHanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
THL
 
Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022
THL
 
Tietoisku eri rokotteista
Tietoisku eri rokotteistaTietoisku eri rokotteista
Tietoisku eri rokotteista
THL
 

More from THL (20)

Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021
 
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdfNiiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
 
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdfYlitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
 
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdfNieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
 
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdfRaitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
 
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
 
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdfLansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
 
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdfMarkkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
 
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
 
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilastoRikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
 
Synthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in EuropeSynthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in Europe
 
Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021
 
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
 
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdfAktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
 
Kort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationerKort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationer
 
Förvaring av vacciner
Förvaring av vaccinerFörvaring av vacciner
Förvaring av vacciner
 
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
 
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikatauluHanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
 
Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022
 
Tietoisku eri rokotteista
Tietoisku eri rokotteistaTietoisku eri rokotteista
Tietoisku eri rokotteista
 

Recently uploaded

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 

Recently uploaded (20)

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 

Jukka Malm: European Regulatory Framework for Chemicals - Protecting Citizens and the Environment

  • 1. European Regulatory Framework for chemicals – protecting citizens and the environment Jukka Malm Deputy Executive Director European Chemicals Agency 3 December 2019
  • 2. 2 Aims of the framework • Protection of human health and the environment from the harmful effects of chemicals • Support to the efficient functioning of the single market of chemicals • Support the global competitiveness of the European chemicals industry
  • 3. The European Chemicals Agency • EU Agency operating in Helsinki since 2007 • Implementing several European legislations related to chemicals • 600 staff from 28 countries • Funding partly from fees, partly from EU subsidy Our competences: 3
  • 4. Working for the safe use of chemicals Classification, labelling, packaging substances and mixtures Biocides active substances in biocidal products REACH substances as such, in mixtures and articles Waste database of products with substances of concern PIC import and export of hazardous substances POPs persistent organic pollutants Workers occupational exposure limits 4
  • 5. 5 Main actors – REACH and CLP Regulations Providing data Industry gathers information and makes sure risks are managed Risk management European Commission, with support of ECHA and Member States, applies EU-wide risk management measures ECHA and Member States screen and check the data and request more if needed Evaluation
  • 6. More data on chemicals than ever before 201 substances of very high concern 600 risk management proposals 2200 substances checked for compliance 23 000 substances registered under REACH 145 000 substances classified under CLP >2 million study summaries on chemical properties and effects 6
  • 7. • Information on hazards and safe use of 140 000 chemicals • 24 000 daily users echa.europa.eu Visit our regulatory chemicals database – largest in the world
  • 8. 8 Proposed restriction on microplastics Prohibition on ‘placing on the market’ Uses where microplastic releases to the environment are inevitable Derogated uses Natural/biodegradable polymers; uses with no microplastic release; already regulated Mandatory ‘safe use information’ Uses where microplastic release can be minimised with instructions for use Mandatory ‘reporting’ Identity, description of use (function), tonnage, releases Microplasticdefinition
  • 9. System is working but improvements are necessary
  • 10. Reinforce the foundation • Our goal: Robust data is available on all chemicals in Europe • We keep on working on compliance of industry dossiers  Compliant data allows the substances to be adequately classified, labelled and used safely  We can conclude which substances • are of concern; • are currently not of concern; or • need more data for a judgement to be made.  Substances of concern are addressed via regulatory risk management 10
  • 11. REACH Evaluation Action Plan • Ambition: ECHA to check 20% of REACH registrations by 2027 for compliance (current target 5%) • 20% of registrations = around 30% of chemical substances on EU market • Two milestones: • End 2023 for substances in tonnage bands over 100 tonnes/year • End 2027 for substances in the 1-100 tonnage bands/year 11
  • 12. Building on the right foundation • Safe and sustainable use of chemicals by industry • Ensure better compliance of supply chain communication, but also go beyond • Companies should move from reactive to proactive • Encourage companies to integrate chemicals management within corporate sustainability strategies • Promote substitution – data, tools, best practice, capacity building – avoid regrettable substitution • Increasing demands from consumers, retailers & investors 12
  • 13. How investing in chemicals legislation can benefit other legislation areas REACH CLP Biocides Occupational health and safety Waste framework directive Restriction of Hazardous Substances directive (RoHS) End of life vehicles directive Water framework directive Drinking water directive Improved consistency of legislative framework Stronger protection of environment and human health Boosting innovation and promoting safe substitution Knowledge and science for non- toxic material cycles Global standards 13
  • 15. 15
  • 16. The zero pollution ambition is dependent on the sustainable production and use of chemicals “For the health of our citizens, our children and grandchildren, Europe needs to move towards a zero- pollution ambition. I will put forward a cross-cutting strategy to protect citizens’ health from environmental degradation and pollution, addressing air and water quality, hazardous chemicals, industrial emissions, pesticides and endocrine disrupters.” Ursula von der Leyen
  • 17. Chemicals in circular economy • Material = mixture of chemicals • Chemicals, waste, products interface • Continue generating hazard data for substances • Develop tracking and tracing of substances in material cycles • Non-toxic material cycles 17
  • 18. Thank you! jukka.malm@echa.europa.eu Subscribe to our news at echa.europa.eu/subscribe Follow us on Twitter @EU_ECHA Follow us on Facebook Facebook.com/EUECHA